RSSS

Research Solutions is a virtual, asset-light vertical SaaS+AI vendor (Reprints Desk, Scite.ai, Resolute) selling auto-renewing subscriptions to corporate, academic and government researchers. FY2025 is the cleanest profitability inflection in its history: revenue grew 9.9% to $49.1M, gross profit rose 23.2% (margin to 49.3%) faster than sales, operating income jumped 425% to $2.50M, and net income turned positive at $1.27M after a $3.79M loss in FY2024. Most important, operating cash flow nearly doubled to $7.02M against effectively zero capex ($19.3K), and cash doubled to $12.2M. The business model — multi-tenant SaaS, prepaid annual contracts, a virtual company with no office — is structurally cash-generative, and the MD&A's emphasis on AI/Generative-AI assistants and content licensing 'for the training of AI models' points to a genuine, timely demand tailwind.

The catch is that the headline GAAP valuation looks stretched (57x trailing EPS of $0.04), and the better lens is cash flow: at a $75.2M market cap the stock trades around ~11x operating cash flow, which is reasonable-to-cheap for a profitable SaaS but not a giveaway given only 9.9% revenue growth. Quality is improving but still lumpy — the company has posted losses in three of the last five years (FY2021, FY2022, FY2024), carries a -$25.0M accumulated deficit, and runs negative net working capital (current assets $20.0M vs current liabilities $25.5M, 0.78x). Much of that current liability is likely deferred revenue typical of prepaid SaaS rather than financial debt, and equity grew 19.1% to $13.9M, so the 2.31x liabilities/equity ratio overstates true leverage — but the PNC loan covenant that blocks dividends is a reminder this is a small, bank-financed balance sheet, not a fortress.